Takeda Pharmaceutical Co Ltd
TSE:4502
Wall Street
Price Targets
Price Targets Summary
Takeda Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for Takeda Pharmaceutical Co Ltd is 4 881.34 JPY with a low forecast of 4 242 JPY and a high forecast of 6 090 JPY.
Price Targets
Operating Income
Forecast
Operating Income Estimate
Takeda Pharmaceutical Co Ltd
For the last 8 years the compound annual growth rate for Takeda Pharmaceutical Co Ltd's operating income is 26%. The projected CAGR for the next 2 years is 35%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Takeda Pharmaceutical Co Ltd's stock price target?
Price Target
4 881.34
JPY
According to Wall Street analysts, the average 1-year price target for Takeda Pharmaceutical Co Ltd is 4 881.34 JPY with a low forecast of 4 242 JPY and a high forecast of 6 090 JPY.
What is Takeda Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
1%
For the last 8 years the compound annual growth rate for Takeda Pharmaceutical Co Ltd's revenue is 11%. The projected CAGR for the next 3 years is 1%.
What is Takeda Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
35%
For the last 8 years the compound annual growth rate for Takeda Pharmaceutical Co Ltd's operating income is 26%. The projected CAGR for the next 2 years is 35%.
What is Takeda Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
-1%
The compound annual growth rate of Takeda Pharmaceutical Co Ltd's net income for the next 3 years is -1%.